LEXINGTON, Mass., May 22, 2025 /PRNewswire/ -- Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel, targeted, small molecule cancer therapeutics, today announced that a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback